Information on this website is exclusively for health care professionals and not the general public.
Are you a qualified Secondary-Care Pharmacist or healthcare professional?
After TGN1412: the CHMP draft guidelines
Hospital Pharmacy Europe Issue 33 July/August 2007
Issues surrounding application of traditional development strategies to biological products were foregrounded last year when a new antibody caused severe reactions in trial volunteers. Will the incident trigger enhanced guidance on testing humanised medicines?
You must login to continue reading this article
Log in to Hospital Pharmacy Europe
Forgotten your password? Click this button and we will send you a reminder by email.
Not yet registered?
Need advice? Try the help section.